The cost of insulin for treating type 1 diabetes in the U.S. nearly doubled over a five-year period, underscoring a national outcry over rising drug prices, according to a new analysis shared with Reuters.
Jan 17- Independent experts on an advisory panel to the U.S. Food and Drug Administration were divided over whether to recommend approval of a treatment for type 1 diabetes developed by Lexicon Pharmaceuticals Inc and France's Sanofi SA. At the panel meeting, patients who were part of the trials advocated the drug's effectiveness, but FDA staff flagged the risk...
Jim Cramer breaks down the potential behind struggling shipping giant UPS.
Jan 16- An advisory panel to the U.S. Food and Drug Administration said on Wednesday that benefits of Amgen Inc's osteoporosis treatment for postmenopausal women at high risk for fracture outweighed its risks and overwhelmingly voted for the drug's approval. The panel, however, raised concerns of cardiovascular safety risks linked to the drug, which FDA staff...
Police in China's eastern province of Jiangsu have begun an investigation after at least 145 children received expired polio vaccines, the Global Times said on Monday.
Jan 11- Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $8 billion purchase of Loxo Oncology this week, but it plans to remain on the sidelines when it comes to two of the hottest areas of drug development. Lilly Chief Executive Dave Ricks told Reuters that as the company looks for deals to enhance its pipeline of future treatments it...
Jan 11- An estimated 69,000 to 84,000 Americans were hospitalized due to the flu in the last three months, the Centers for Disease Control and Prevention said on Friday. Between Oct. 1, 2018 and Jan. 5, 2019, about 6 million to 7 million people were reported to have contracted the flu, according to data collected by the health agency. Health regulators have been trying...
Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products.
Jim Cramer explains why renewed strength in the retail and housing stocks could make the Fed rethink the rate hike pause.
The National Cannabis Industry Association counters by saying: "So far, there is nothing to suggest that cannabis consumption causes mental illness."
Jim Cramer and Allergan Chairman, President and CEO Brent Saunders discuss how the pharmaceutical company will tackle Wall Street pessimism.
Jim Cramer speaks to Bausch Health Companies Chairman and CEO Joseph Papa about his company's turnaround, competition and 2019 prospects.
Jim Cramer explains why it might be worth picking up shares of Micron now despite a possible negative quarter on the horizon.
Jim Cramer sits down with Amgen Chairman and CEO Bob Bradway to hear about the company's recent price cut for one of its key drugs.
Jim Cramer and Novartis CEO Vas Narasimhan discuss how the drugmaker is refocusing its business to leverage new-age treatments and potential cures.
Jim Cramer says leading drugmakers are innovating more than ever before and many of their stocks are worth owning.
WASHINGTON, Jan 7- The U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to reinstate a jury verdict it won against rivals Regeneron Pharmaceuticals Inc and Sanofi SA in a patent dispute over cholesterol medication. The justices turned away Amgen's appeal of a 2017 decision by a lower court to set aside a jury's verdict that two Amgen patents were...
*Baselga resigned from Sloan Kettering Cancer Center. The 59- year-old Spaniard resigned as chief medical officer of Memorial Sloan Kettering Cancer Center in September after the New York Times and Pro Publica revealed that he had not disclosed millions of dollars in payments from healthcare firms. "The American Association of Cancer Research...
WASHINGTON, Jan 7- The U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to reinstate a jury verdict it won against rivals Regeneron Pharmaceuticals Inc and Sanofi SA in patent dispute over cholesterol medication. The justices turned away Amgen's appeal of a 2017 decision by a lower court to set aside a jury's verdict that two Amgen patents were...
Baselga resigned as the chief medical officer of Memorial Sloan Kettering Cancer Center in September 2018 after the New York Times and Pro Publica revealed that he had not disclosed millions of dollars in payments from healthcare firms. Baselga, who has helped develop cancer therapies for more than 30 years, also worked as the chief of the division of...
Data also provided by 
